Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: Implications for Parkinson's disease

Journal of Neurochemistry

Volumn 73, Issue 3, 1999, Pages 1127-1137

  Berman, Sarah B ^a   Hastings, Teresa G ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; Mitochondria; Parkinson's disease; Permeability transition; Quinone; Respiration

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CATALASE; CYCLOSPORIN A; DOPAMINE; GLUTATHIONE; HYDROGEN PEROXIDE; PARGYLINE; QUINONE DERIVATIVE; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; BRAIN MITOCHONDRION; CELL DEATH; CELL MEMBRANE PERMEABILITY; DOPAMINE METABOLISM; MALE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION SWELLING; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATION; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; CELL MEMBRANE PERMEABILITY; CYCLOSPORINE; DOPAMINE; MALE; MITOCHONDRIA; MITOCHONDRIA, LIVER; MITOCHONDRIAL SWELLING; MONOAMINE OXIDASE; MONOPHENOL MONOOXYGENASE; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032842038     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0731127.x     Document Type: Article

References (80)

1. Benard O. and Balasubramanian K. A. (1995) Effect of oxidized glutathione on intestinal mitochondria and brush border membrane. Int. J. Biochem. Cell Biol. 27, 589-595.
2. Ben-Shachar D., Zuk R., and Glinka Y. (1995) Dopamine neurotoxicity: inhibition of mitochondrial respiration. J. Neurochem. 64, 718-723.
3. Berman S. B. and Hastings T. G. (1997) Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species. J. Neurochem. 69, 1185-1195.
4. Berman S. B., Zigmond M. J., and Hastings T. G. (1996) Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J. Neurochem. 67, 593-600.
5. Bernardi P. (1995) The permeability transition pore. History and perspectives of a cyclosporin A-sensitive mitochondrial channel. Prog. Cell Res. 5, 119-123.
6. Bernardi P., Vassanelli S., Veronese P., Raffaele C., Szabo I., and Zoratti M. (1992) Modulation of the mitochondrial permeability transition pore: effect of protons and divalent cations. J. Biol. Chem. 267, 2934-2939.
7. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., and Seitelberger F. (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J. Neurol. Sci. 20, 415-455.
8. Bowling A. C. and Beal M. F. (1995) Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci. 56, 1151-1171.
9. Bradford M. A. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
10. Brand M. D., Chien L.-F., Ainscow E. D., Rolfe D. F. S., and Porter R. K. (1994) The causes and functions of mitochondrial proton leak. Biochim. Biophys. Acta 1187, 132-139.
11. Broekemeier K. M., Dempsey M. E., and Pfeiffer D. R. (1989) Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J. Biol. Chem. 264, 7826-7830.
12. Brookes P. S., Land J. M., Clark J. B., and Heales S. J. R. (1998) Peroxynitrite and brain mitochondria: evidence for increased proton leak. J. Neurochem. 70, 2195-2202.
13. Cadenas E. (1995) Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem. Pharmacol. 49, 127-140.
14. Cassarino D. S., Fall C. P., Smith T. S., and Bennett J. P. Jr. (1998) Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion. J. Neurochem. 71, 295-301.
15. Chance B. and Williams G. R. (1956) The respiratory chain and oxidative phosphorylation. Adv. Enzymol. 17, 65-134.
16. Chernyak B. V. and Bernardi P. (1996) The mitochondrial permeability transition pore is modulated by oxidative agents through both pyridine nucleotides and glutathione at two separate sites. Eur. J. Biochem. 238, 623-630.
17. Cohen G., Farooqui R., and Kesler N. (1997) Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. Proc. Natl. Acad. Sci. USA 94, 4890-4894.
18. 2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem. J. 255, 357-360.
19. Cubbells J. F., Rayport S., Rajendran G., and Sulzer D. (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14, 2260-2271.
20. Davey G. P. and Clark J. B. (1996) Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria. J. Neurochem. 66, 1617-1624.
21. Deckwerth T. L. and Johnson E. M. (1993) Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J. Cell Biol. 123, 1207-1222.
22. Ellerby H. M., Martin S. J., Ellerby L. M., Naiem S. S., Rabizadeh S., Salvesen G. S., Casiano C. A., Cashman N. R., Green D. R., and Bredesen D. E. (1997) Establishment of a cell-free system of neuronal apoptosis: comparison of premitochondrial, mitochondrial, and postmitochondrial phases. J. Neurosci. 17, 6165-6178.
23. Fahn S. and Cohen G. (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32, 804-812.
24. Filloux F. and Townsend J. J. (1993) Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp. Neurol. 119, 79-88.
25. Fornstedt B., Brun A., Rosengren E., and Carlsson A. (1989) The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra. J. Neural Transm. 1, 279-295.
26. Fornstedt B., Bergh I., Rosengren E., and Carlsson A. (1990) An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid. J. Neurochem. 54, 578-586.
27. Fournier N., Ducet G., and Crevat A. (1987) Action of cyclosporine on mitochondrial calcium fluxes. J. Bioenerg. Biomembr. 19, 297-303.
28. Friberg H., Ferrand-Drake M., Bengtsson F., Halestrap A. P., and Wieloch T. (1998) Cyclosporin A, but not FK506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J. Neurosci. 18, 5151-5159.
29. Graham D. G. (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14, 633-643.
30. Greenawalt J. W. and Schnaitman C. (1970) An appraisal of the use of monoamine oxidase as an enzyme marker for the outer membrane of rat liver mitochondria. J. Cell Biol. 46, 173-179.
31. Gunter T. E. and Pfeiffer D. R. (1990) Mechanisms by which mitochondria transport calcium. Am. J. Physiol. 258, C755-C786.
32. Hafner R. P., Brown G. C., and Brand M. D. (1990) Analysis of the control of respiration rate, phosphorylation rate, proton leak rate and protonmotive force in isolated mitochondria using the "top-down" approach. Eur. J. Biochem. 188, 313-319.
33. Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
34. Hastings T. G. (1995) Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J. Neurochem. 64, 919-924.
35. 3H]dopamine: impact of ascorbic acid and glutathione. J. Neurochem. 63, 1126-1132.
36. Hastings T. G., Lewis D., and Zigmond M. J. (1996) Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. USA 93, 1956-1961.
37. Henry T. R. and Wallace K. B. (1995) Differential mechanisms of induction of the mitochondrial permeability transition by quinones of varying chemical reactivities. Toxicol. Appl. Pharmacol. 134, 195-203.
38. Henry T. R., Solem L. E., and Wallace K. B. (1995) Channel-specific induction of the cyclosporine A-sensitive mitochondrial permeability transition by menadione. J. Toxicol. Environ. Health 45, 489-504.
39. Kenney W. C. (1975) The reaction of N-ethylmaleimide at the active site of succinate dehydrogenase. J. Biol. Chem. 250, 3089-3094.
40. Koga S., Nakano M., and Tero-Kuboto S. (1992) Generation of superoxide during the enzymatic action of tyrosinase. Arch. Biochem. Biophys. 292, 570-575.
41. Kuhn D. M. and Arthur R. (1998) Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein - possible endogenous toxin to serotonin neurons. J. Neurosci. 18, 7111-7117.
42. LaVoie M. J. and Hastings T. G. (1999) Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J. Neurosci. 19, 1484-1491.
43. Liu X., Kim C. N., Yang J., Jemmerson R., and Wang X. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147-157.
44. Maker H. S., Weiss C., Silides D. J., and Cohen G. (1981) Coupling of dopamine oxidation (monoamine oxidase activity) to glutathione oxidation via the generation of hydrogen peroxide in rat brain homogenates. J. Neurochem. 36, 589-593.
45. Mann V. M., Cooper J. M., Krige D., Daniel S. E., Schapira A. H., and Marsden C. D. (1992) Brian, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 115, 333-342.
46. Martin M. A., Molina J. A., Jimenez-Jimenez F. J., Benito-Leon J., Orti-Pareja M., Campos Y., and Arenas J. (1996) Respiratory chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson's disease patients. Neurology 46, 1343-1346.
47. Michel P. P. and Hefti F. (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 26, 428-435.
48. Morikawa N., Nakagawa-Hattori Y., and Mizuno Y. (1996) Effect of dopamine, dimethoxyphenylethylamine, papaverine, and related compounds on mitochondrial respiration and complex I activity. J. Neurochem. 66, 1174-1181.
49. Nieminen A.-L., Petrie T. G., LeMasters J. J., and Selman W. R. (1996) Cyclosporin A delays mitochondrial depolarization induced by N-methyl-D-aspartate in cortical neurons: evidence of the mitochondrial permeability transition. Neuroscience 75, 993-997.
50. Ouyang Y. B., Kuroda S., Kristian T., and Siesjö B. K. (1997) Release of mitochondrial aspartate aminotransferase (MAST) following transient focal cerebral ischemia suggests the opening of a mitochondrial permeability transition pore. Neurosci. Res. Commun. 20, 167-173.
51. +) and nitric oxide simultaneously causes cyclosporin A-sensitive mitochondrial calcium efflux and depolarisation. Biochem. Pharmacol. 51, 267-273.
52. Palmeira C. M. and Wallace K. B. (1997) Benzoquinone inhibits the voltage-dependent induction of the mitochondrial permeability transition caused by redox-cycling naphthoquinones. Toxicol. Appl. Pharmacol. 143, 338-347.
53. Parker W. D., Boyson S. J., and Parks J. K. (1989) Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 26, 719-723.
54. Petit P. X., LeCoeur H., Zorn E., Duguet C., Mignotte B., and Gougeon M. L. (1995) Alterations of mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell Biol. 130, 157-167.
55. Petronilli V., Costantini P., Scorrano L., Colonna R., Passamonti S., and Bernardi P. (1994) The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols: increase of the gating potential by oxidants and its reversal by reducing agents. J. Biol. Chem. 269, 16638-16642.
56. Przedborski S., Jackson-Lewis V., Muthane U., Jiang H., Ferreira M., Naini A. B., and Fahn S. (1993) Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity. Ann. Neurol 34, 715-723.
57. Radi R., Bechman J. S., Bush K. M., and Freeman B. A. (1991) Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 206, 4244-4250.
58. Rosenthal R. E., Hamud F., Fiskum G., Varghese P. J., and Sharpe S. (1987) Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine. J. Cereb. Blood Flow Metab. 7, 752-758.
59. Savage M. K., Jones D. P., and Reed D. J. (1991) Calcium- and phosphate-dependent release and loading of glutathione by liver mitochondria. Arch. Biochem. Biophys. 290, 51-56.
60. Schapira A. H. V., Cooper J. M., Dexter D., Clark J. B., Jenner P., and Marsden C. D. (1990a) Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54, 823-827.
61. 1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 55, 2142-2145.
62. Schinder A. F., Olson E. C., Spitzer N. C., and Montal M. (1996) Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 16, 6125-6133.
63. Sheehan J. P., Swerdlow R. H., Parker W. D., Miller S. W., Davis R. E., and Tuttle J. B. (1997) Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease. J. Neurochem. 68, 1221-1233.
64. Shoffner J. M., Watts R. L., Juncos J. L., Torroni A., and Wallace D. C. (1991) Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann. Neurol. 30, 332-339.
65. Spencer J. P. E., Jenner P., Daniel S. E., Lees A. J., Marsden D. C., and Halliwell B. (1998) Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species. J. Neurochem. 71, 2112-2122.
66. Stephans S. E. and Yamamoto B. K. (1994) Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 17, 203-209.
67. Sulzer D., Chen T.-K., Lau Y. Y., Kristensen H., Rayport S., and Ewing A. (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15, 4102-4108.
68. Susin S. A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., Daugas E., Geuskens M., and Kroemer G. (1996) Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184, 1331-1341.
69. Tomita Y., Hariu A., Kato C., and Seiji M. (1984) Radical production during tyrosinase reaction, dopa-melanin formation, and photoirradiation of dopa-melanin. J. Invest. Dermatol. 82, 573-576.
70. Tse D. C. S., McCreery R. L., and Adams R. N. (1976) Potential oxidative pathways of brain catecholamines. J. Med. Chem. 19, 37-40.
71. Uchino H., Elmér E., Uchino K., Lindvall O., and Siesjö B. K. (1995) Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat. Acta Physiol. Scand. 155, 469-471.
72. Valle V. G. R., Fagian M. M., Parentoni L. S., Meinicke A. R., and Vercesi A. E. (1993) The participation of reactive oxygen species and protein thiols in the mechanism of mitochondrial inner membrane permeabilization by calcium plus prooxidants. Arch. Biochem. Biophys. 307, 1-7.
73. Vayssiére J.-L., Petit P. X., Risler Y., and Mignotte B. (1994) Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. Proc. Natl. Acad. Sci. USA 91, 11752-11756.
74. White R. J. and Reynolds I. J. (1996) Mitochondrial depolarization in glutamate-stimulated neurons: an early signal specific to excitotoxin exposure. J. Neurosci. 16, 5688-5697.
75. Xu Y. M., Stokes A. H., Roskoski R., and Vrana K. E. (1998) Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase. J. Neurosci. Res. 54, 691-697.
76. o of ATP synthase essential for ATPase activity. Arch. Biochem. Biophys. 254, 102-109.
77. Zamzami N., Marchetti P., Castedo M., Zanin C., Vayssiere J.-L., Petit P. X., and Kroemer G. (1995a) Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181, 1661-1672.
78. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S. A., Petit P. X., Mignotte B., and Kroemer G. (1995b) Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182, 367-377.
79. Zamzami N., Susin S. A., Marchetti P., Hirsch T., Gómez-Monterrey I., Castedo M., and Kroemer G. (1996) Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183, 1533-1544.
80. Zhang Y., Marcillat O., Giulivi C., Ernster L., and Davies K. J. A. (1990) The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem. 265, 16330-16336.